NDC 55111-194 is a in the category. It is labeled and distributed by .
Proprietary Name | NDC 55111-194 |
Marketing Category | / |
Marketing Category | ANDA |
Application Number | ANDA076502 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2006-04-12 |
Marketing End Date | 2011-01-25 |
Marketing Category | ANDA |
Application Number | ANDA076502 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-04-12 |
Marketing End Date | 2011-01-25 |
Marketing Category | ANDA |
Application Number | ANDA076502 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-04-12 |
Marketing End Date | 2011-01-25 |
Marketing Category | ANDA |
Application Number | ANDA076502 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2006-04-12 |
Marketing End Date | 2011-01-25 |
Marketing Category | ANDA |
Application Number | ANDA076502 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-04-12 |
Marketing End Date | 2011-01-25 |
Marketing Category | ANDA |
Application Number | ANDA076502 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-01-25 |
Marketing End Date | 2011-01-25 |
Marketing Category | ANDA |
Application Number | ANDA076502 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2006-04-12 |
Marketing End Date | 2011-01-25 |